Lantheus Holdings, Inc. Total Liabilities
Lantheus Holdings, Inc. (LNTH) had Total Liabilities of $1.10 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-06
- 2026-06-30: Liabilities $1.10B.
- 2026-03-31: Liabilities $1.13B.
- 2025-12-31: Liabilities $1.14B.
- 2025-09-30: Liabilities $1.16B.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $1.10B 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.13B 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.14B 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.16B 10-Q · filed 2025-11-06 |
| 2025-06-30 | $949.29M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $891.03M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $892.33M 10-K · filed 2026-02-26 |
| 2024-09-30 | $869.92M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $913.15M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $885.79M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $835.26M 10-K · filed 2025-02-26 |
| 2023-09-30 | $822.85M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $785.08M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $903.77M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $874.11M 10-K · filed 2024-02-22 |
| 2022-09-30 | $457.89M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $446.49M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $417.32M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $399.35M 10-K · filed 2023-02-23 |
| 2021-09-30 | $348.47M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $349.66M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $315.33M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $355.62M 10-K · filed 2022-02-24 |
| 2020-09-30 | $366.01M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $364.11M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $285.73M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $291.32M 10-K · filed 2021-02-25 |
| 2019-09-30 | $301.24M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $298.00M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $360.69M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $368.83M 10-K · filed 2020-02-25 |
| 2018-09-30 | $369.31M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $357.27M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $358.93M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $360.57M 10-K · filed 2019-02-20 |
| 2017-09-30 | $358.94M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $355.06M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $350.72M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $362.41M 10-K · filed 2018-02-26 |
| 2016-09-30 | $376.13M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $425.63M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $423.48M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $427.67M 10-K · filed 2017-02-23 |
| 2015-09-30 | $426.28M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $429.13M 10-Q · filed 2015-08-05 |
| 2014-12-31 | $482.42M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |